Article
Anaheim, Calif. - Topical imiquimod, systemic retinoids, and sentinellymph node biopsies are dermatologic tools that instigate promise and controversywhen discussing their role in managing basal cell carcinoma, squamous cellcarcinoma, and primary cutaneous melanoma, respectively.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.